KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Non Operating Investment Income (2016 - 2023)

Historic Non Operating Investment Income for CareDx (CDNA) over the last 8 years, with Q2 2023 value amounting to $3000.0.

  • CareDx's Non Operating Investment Income fell 9375.0% to $3000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $3000.0, marking a year-over-year decrease of 9655.17%. This contributed to the annual value of $2.1 million for FY2023, which is 187102.8% up from last year.
  • Per CareDx's latest filing, its Non Operating Investment Income stood at $3000.0 for Q2 2023, which was down 9375.0% from $7000.0 recorded in Q1 2023.
  • In the past 5 years, CareDx's Non Operating Investment Income ranged from a high of $4.3 million in Q3 2019 and a low of -$3.0 million during Q1 2019
  • In the last 5 years, CareDx's Non Operating Investment Income had a median value of $16000.0 in 2022 and averaged -$52944.4.
  • In the last 5 years, CareDx's Non Operating Investment Income crashed by 25165.17% in 2020 and then skyrocketed by 17384.62% in 2022.
  • Quarter analysis of 5 years shows CareDx's Non Operating Investment Income stood at $333000.0 in 2019, then plummeted by 251.65% to -$505000.0 in 2020, then soared by 111.09% to $56000.0 in 2021, then plummeted by 67.86% to $18000.0 in 2022, then plummeted by 83.33% to $3000.0 in 2023.
  • Its Non Operating Investment Income was $3000.0 in Q2 2023, compared to $7000.0 in Q1 2023 and $18000.0 in Q4 2022.